{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-006307","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.277641+00:00","generated_at":"2026-05-16T08:23:22.143670+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Coherus Oncology files prospectus supplement for $64.9M ATM stock offering","bullets":["Aggregate offering price of up to $64,880,054 under Sales Agreement with TD Cowen.","Shares of common stock may be sold from time to time at then-prevailing market prices.","Legal opinion of Latham & Watkins on share validity filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-006307","json":"https://secwatch.observer/filing/0001104659-26-006307.json","markdown":"https://secwatch.observer/filing/0001104659-26-006307.md","text":"https://secwatch.observer/filing/0001104659-26-006307.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926006307/0001104659-26-006307-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926006307/tm263459d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:23:22.143670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}